Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2409 of 6351
-
Anti-aging pill? singapore trial tests AKG on biological age
Knowledge-focused OngoingGeroscience is an emerging interdisciplinary field of study in gerontological sciences. With emphasis on understanding the mechanistic drivers of aging, it seeks translational approaches that could eventually be applied to improve human healthspan and delay age-associated chronic…
Phase 2 • Sponsor: National University of Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New combo pill tackles blood pressure and cholesterol at once
Disease control CompletedThis study aims to evaluate the efficacy and safety of co-administration of DWC202206 and DWC202207 in patients with concomitant hypertension and hyperlipidemia.
Phase 3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Dream control: a new behavioral approach to tame narcolepsy nightmares
Symptom relief CompletedThe goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: * Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? * Does adding targeted dream control (TDC) t…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Real-World data shows Mavacamten's impact on heart condition
Disease control CompletedThe purpose of this study is to evaluate the real-world outcomes of individuals diagnosed with obstructive hypertrophic cardiomyopathy (oHCM) treated with mavacamten at the Hospital of The University of Pennsylvania in the US
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 15:36 UTC
-
Smartwatch coaching eases Runner's knee in small trial
Symptom relief CompletedPatellofemoral pain (PFP) is the most common running-related overuse injury, with prevalence up to 17% among runners. Increased patellofemoral joint stress (PFJS) is a major biomechanical contributor to PFP. Traditional strengthening exercises improve function but do not alter ru…
Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jun 26, 2026 17:46 UTC
-
New eye drops aim to replace reading glasses – but are they safe Long-Term?
Disease control CompletedSafety Study of the Long-Term Safety of LNZ100 \& LNZ101 in Presbyopic Subjects
Phase 3 • Sponsor: LENZ Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Asthma drug benralizumab put to the test in everyday life
Disease control CompletedThis study aims to generate real-world data on the characteristics of patients receiving benralizumab to assess early PRO parameters as well as long-term treatment effects in the Gulf cooperative council (Kingdom of Saudi Arabia, Kuwait, United Arab Emirates, Oman, and Qatar), La…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New HIV pill combo aims to keep virus suppressed with just one daily tablet
Disease control OngoingThe primary objectives of this study are to evaluate the safety and tolerability of a switch to Doravirine/Islatravir (DOR/ISL) compared with continued baseline antiretroviral therapy (ART), through Week 48; and to evaluate the antiretroviral activity of a switch to DOR/ISL compa…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a computer program help calm anxiety in dementia?
Symptom relief OngoingThis study is a randomized controlled trial (RCT) of a remotely-delivered, technology-assisted psychotherapy program, supported by an innovative software platform for people with cognitive impairment experiencing anxiety.
Sponsor: The University of Queensland • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Which bariatric surgery wins? new trial pits SASI bypass against sleeve gastrectomy
Disease control Recruiting nowThis study will compare two bariatric surgical interventions in terms of weight loss, gastroesophageal reflux, and effects on obesity-related comorbid conditions in morbidly obese patients.
Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Brain tumor samples used to tailor drug cocktails in recurrent glioma trial
Knowledge-focused Recruiting nowThis is an interventional, non-randomized, single site study. Brain tumor samples will be collected from patients for organoids generation and subject to panel drugs screening and QPOP analysis to derive the optimal drug combinations for treatment at the time of first high grade …
Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Smartphone app could improve blood sugar control in type 2 diabetes
Disease control CompletedThe Connected Solution investigated in this study is the combination of the titration module "Insultrate" and a cell phone application (app) named Health2Sync (H2S) that synchronizes participants' self-monitoring blood glucose data and electronic health records to a platform over…
Sponsor: Sanofi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Exercise as medicine: new trial tests workouts for heart condition
Symptom relief Recruiting nowThe EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruite…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Could a new Once-Daily pill keep HIV in check? major trial underway
Disease control OngoingThe primary objectives of this study are to evaluate the antiretroviral activity of a switch to Doravirine/Islatravir (DOR/ISL) compared with continued Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) at Week 48; and to evaluate the safety and tolerability of a switc…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can switching to a vegan diet for one month change your body and blood?
Knowledge-focused CompletedAt baseline, venous blood samples were collected from all eligible participants. The following biochemical parameters were analysed: serum electrolytes (mineral profile), fasting glucose, creatinine, urea nitrogen, total proteins, albumin, bilirubin, liver enzymes, C-reactive pro…
Sponsor: University Hospital, Martin • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Heart rhythm mystery: 750-Patient study targets AF recurrence after ablation
Knowledge-focused Recruiting nowAtrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood. The aim of the PROSPECT-AF study is to assess the pre…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
HIV treatment showdown: could simpler drug regimens reduce inflammation?
Knowledge-focused OngoingHIV-infected patients develop comorbidities earlier than the general population. Immune activation with the secretion of pro-inflammatory cytokines would play a major role in the occurrence of these comorbidities. Numerous factors, called risk factors, already identified in the g…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Experimental combo aims to boost leukemia remission
Disease control Recruiting nowThe purpose of the study is to determine the safety of combining the drugs gemtuzumab ozogamicin (GO) with CPX-351 in order to treat the disease, as well as to find the maximum tolerated dose level and recommended Phase 2 dose level of GO with a fixed dose of CPX-351.
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Weekly shot may replace daily growth hormone for turner syndrome kids
Disease control OngoingA 104 week dose finding open label trial followed by an optional 78 week open label extension of lonapegsomatropin, a long-acting growth hormone product, administered once-a-week versus daily somatropin product in prepubertal individuals with Turner syndrome. Approximately 48 ind…
Phase 2 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Experimental HIV vaccine shows promise in early safety trial
Disease control CompletedThe clinical trial is a dose-escalation, randomized, double-blind, placebo-controlled phase I study at a single center to evaluate the safety, tolerability and immunogenicity of HIV Therapeutic DNA Vaccine, ICVAX, in clinically stable HIV patients under ART treatment.
Phase 1 • Sponsor: Immuno Cure Holding (HK) Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC